DOSEOLOGY SCIENCES INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.149 USD | -36.02% |
|
-.--% | -33.48% |
| 13/05 | Doseology Sciences Inc. Announces CFO Changes | CI |
| 13/05 | Doseology Sciences Inc. Announces Expansion of Distribution Reach | CI |
More news
More press releases
| 1 day | -36.02% | ||
| 3 months | +24.17% | ||
| 6 months | -33.48% | ||
| Current year | -33.48% |
Current year
0.01
0.47
1 year
0.010.72
3 years
0.011.00
5 years
0.011.00
10 years
0.011.00
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Vice
FOU | Founder | 35 | 10/19/10 |
Shawn Balaghi
CEO | Chief Executive Officer | 55 | 05/23/05 |
Basin
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Scott Reeves
BRD | Director/Board Member | 55 | 27/20/27 |
Shawn Balaghi
CEO | Chief Executive Officer | 55 | 05/23/05 |
Daniel Vice
FOU | Founder | 35 | 10/19/10 |
Lucy Scientific Discovery Inc., formerly Doseology Sciences Inc., is an early-stage psychedelic manufacturing company. The Company is focused on research, development and manufacturing for the emerging psychedelic-based medicine industry. The Company is advancing the frontiers of mind science and facilitating the development of psychotropic and psychedelic treatment therapies, medicines, and commercial products. It is engaged in developing consumer product manufacturing, marketing and distribution. The Company is dedicated to the production of a variety of natural, synthetic and biosynthetic products to meet the needs of the psychotropics-based medicine market.
Sector
Pharmaceuticals
Calendar
28/10/2024
- Q4 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +55.32% | 82TCr | |
| +44.05% | 64TCr | |
| -6.75% | 35TCr | |
| +13.56% | 31TCr | |
| +10.68% | 30TCr | |
| +16.57% | 24TCr | |
| +13.31% | 22TCr | |
| +8.48% | 17TCr | |
| -2.81% | 16TCr |
- Stock Market
- Equities
- MOOD Stock
- DOSEF Stock
